Actelion Pharmaceuticals Ltd. is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland...
25 KB (2,584 words) - 21:16, 20 October 2024
After Actelion was bought by Johnson & Johnson in 2017, Idorsia was spun out into a new company and started operating on the same campus where Actelion was...
6 KB (377 words) - 13:24, 9 June 2024
approved for medical use in the European Union in June 2023. In July 2004, Actelion started a clinical trial of miglustat to treat Tay–Sachs disease, particularly...
21 KB (1,687 words) - 09:47, 20 August 2024
acquired Actelion in a $30 billion deal, the largest ever purchase by the company. After the purchase, Johnson & Johnson spun off Actelion's research...
116 KB (11,245 words) - 23:59, 4 November 2024
Abbott – Abbott Laboratories Inc. Accord – Accord Healthcare Ltd. Actelion – Actelion Pharmaceuticals UK Ltd Aesica pharmaceuticals - Aesica Queenborough...
8 KB (815 words) - 00:56, 9 July 2024
and more". www.medicalnewstoday.com. 2023-04-14. Retrieved 2023-12-04. "Actelion to buy Ceptaris - if FDA backs its cancer treatment". PMLive. 2013-08-01...
25 KB (1,860 words) - 04:49, 26 July 2024
brand name Opsumit, is an endothelin receptor antagonist developed by Actelion and approved for the treatment of pulmonary arterial hypertension (PAH)...
11 KB (1,012 words) - 16:29, 7 September 2024
orexin receptors, which was being developed by the pharmaceutical companies Actelion and GSK for the treatment of insomnia. Development of the drug was abandoned...
8 KB (606 words) - 16:15, 31 March 2024
Specialty Chemicals, Clariant, Hoffmann-La Roche, Basilea Pharmaceutica, and Actelion are headquartered there. Pharmaceuticals and specialty chemicals have become...
142 KB (13,966 words) - 21:36, 31 October 2024
Selexipag, sold under the brand name Uptravi, is a medication developed by Actelion for the treatment of pulmonary arterial hypertension (PAH). Selexipag and...
14 KB (909 words) - 05:22, 7 April 2024